162 related articles for article (PubMed ID: 32850336)
21. DLX6-AS1: A Long Non-coding RNA With Oncogenic Features.
Ghafouri-Fard S; Najafi S; Hussen BM; Ganjo AR; Taheri M; Samadian M
Front Cell Dev Biol; 2022; 10():746443. PubMed ID: 35281110
[TBL] [Abstract][Full Text] [Related]
22. Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value.
Lin Y; Zhang B; Su L; Wei J; Chen Z; Wu M
Biotechnol Genet Eng Rev; 2023 Apr; ():1-12. PubMed ID: 37078565
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
Li D; Tang X; Li M; Zheng Y
J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
25. LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.
Yang Q; Sun J; Ma Y; Zhao C; Song J
Am J Transl Res; 2019; 11(11):7009-7017. PubMed ID: 31814904
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA DLX6-AS1 is upregulated in preeclampsia and modulates migration and invasion of trophoblasts through the miR-376c/GADD45A axis.
Tan Y; Xiao D; Xu Y; Wang C
Exp Cell Res; 2018 Sep; 370(2):718-724. PubMed ID: 30055134
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
Wu SB; Wang HQ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
[TBL] [Abstract][Full Text] [Related]
28. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
Ding XZ; Zhang SQ; Deng XL; Qiang JH
Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region.
Zhao H; Xu Q
J Cell Mol Med; 2020 Nov; 24(21):12572-12584. PubMed ID: 32951317
[TBL] [Abstract][Full Text] [Related]
30. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
Tian S; Liu J; Kong S; Peng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
32. DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer.
Zhu X; Ma X; Zhao S; Cao Z
Environ Toxicol; 2021 Mar; 36(3):308-319. PubMed ID: 33035382
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.
Tian Y; Wang YR; Jia SH
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7307-7313. PubMed ID: 31539117
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury.
Tan J; Fan J; He J; Zhao L; Tang H
J Bioenerg Biomembr; 2020 Oct; 52(5):367-376. PubMed ID: 32666494
[TBL] [Abstract][Full Text] [Related]
35. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.
Li J; Li P; Zhao W; Yang R; Chen S; Bai Y; Dun S; Chen X; Du Y; Wang Y; Zang W; Zhao G; Zhang G
Cancer Cell Int; 2015; 15():48. PubMed ID: 26052251
[TBL] [Abstract][Full Text] [Related]
36. Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer.
Zhang X; Guo H; Bao Y; Yu H; Xie D; Wang X
Oncol Lett; 2019 Nov; 18(5):5197-5204. PubMed ID: 31612030
[TBL] [Abstract][Full Text] [Related]
37. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.
Liu R; Wang X; Yan Q
Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737
[TBL] [Abstract][Full Text] [Related]
38. The lncRNA KIF9-AS1 Accelerates Hepatocellular Carcinoma Growth by Recruiting DNMT1 to Promote RAI2 DNA Methylation.
Yu Y; Lu X; Yan Y; Wang Y; Meng J; Tian S; Mu J
J Oncol; 2022; 2022():3888798. PubMed ID: 36276278
[TBL] [Abstract][Full Text] [Related]
39. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
Qian Y; Song W; Wu X; Hou G; Wang H; Hang X; Xia T
Dig Dis Sci; 2021 Feb; 66(2):460-473. PubMed ID: 32239379
[TBL] [Abstract][Full Text] [Related]
40. Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Frontiers Editorial Office
Front Oncol; 2021; 11():840152. PubMed ID: 35036360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
